Invention Grant
- Patent Title: Substance specific to human PD-1
-
Application No.: US14584664Application Date: 2014-12-29
-
Publication No.: US09783609B2Publication Date: 2017-10-10
- Inventor: Tasuku Honjo , Shiro Shibayama , Kazuhiko Takeda , Masayoshi Matsuo , Takao Yoshida , Masakazu Miyamoto
- Applicant: ONO PHARMACEUTICAL CO., LTD. , Tasuku Honjo
- Applicant Address: JP Osaka JP Kyoto
- Assignee: ONO PHARMACEUTICAL CO., LTD.,Tasuku Honjo
- Current Assignee: ONO PHARMACEUTICAL CO., LTD.,Tasuku Honjo
- Current Assignee Address: JP Osaka JP Kyoto
- Agency: Sughrue Mion, PLLC
- Priority: JP2003-14793 20030123
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K39/00

Abstract:
The present invention relates to a substance specific to human PD-1 comprising a part that recognizes human PD-1, a part that recognizes a membrane protein in cell membrane of human PD-1-expressing cells, and linkers. Since the substance specific to human PD-1 selectively can recognize human PD-1 and a membrane protein on cell membrane of human PD-1-expressing cells and can transmit inhibitory signal of human PD-1, it is useful for therapy and/or prevention of diseases caused by immunopathy.
Public/Granted literature
- US20150118234A1 SUBSTANCE SPECIFIC TO HUMAN PD-1 Public/Granted day:2015-04-30
Information query